GlobeNewswire (Wed, 8:30AM)
Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
638 people get NEPT articles and Market Currents by email alert.
Get email alerts on NEPT »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
GlobeNewswire (Wed, 8:00AM)
-
GlobeNewswire (May 9, 2013)
-
GlobeNewswire (Apr 10, 2013)
-
-
GlobeNewswire (Mar 14, 2013)
-
GlobeNewswire (Jan 31, 2013)
-
GlobeNewswire (Jan 30, 2013)
-
-
GlobeNewswire (Jan 24, 2013)
-
-
GlobeNewswire (Jan 15, 2013)
-
GlobeNewswire (Jan 14, 2013)
-
GlobeNewswire (Jan 7, 2013)
-
GlobeNewswire (Dec 21, 2012)
-
GlobeNewswire (Dec 20, 2012)
-
To learn more about Seeking Alpha Pro, click here.
-
-
-
-
-
Neptune's Dividend Catalyst Finally In PlayM. E. Garza • Mon, Sep 10, 2012 -
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Healthcare Investment Conference RoundupM. E. Garza • Fri, Jan 13, 2012
-
-
-
GlobeNewswire (Wed, 8:30AM)
-
GlobeNewswire (Wed, 8:00AM)
-
GlobeNewswire (May 9, 2013)
-
GlobeNewswire (Apr 10, 2013)
-
GlobeNewswire (Mar 14, 2013)
-
GlobeNewswire (Jan 31, 2013)
-
GlobeNewswire (Jan 30, 2013)
-
GlobeNewswire (Jan 24, 2013)
-
GlobeNewswire (Jan 15, 2013)
-
GlobeNewswire (Jan 14, 2013)
-
GlobeNewswire (Jan 7, 2013)
-
GlobeNewswire (Dec 21, 2012)
-
GlobeNewswire (Dec 20, 2012)
-
GlobeNewswire (Dec 4, 2012)
-
GlobeNewswire (Nov 27, 2012)
-
GlobeNewswire (Nov 26, 2012)
-
GlobeNewswire (Nov 26, 2012)
-
GlobeNewswire (Nov 16, 2012)
NEPT vs. ETF Alternatives
Company Description
Currently, there's no company description for NEPT.
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Wednesday, May 15, 11:58 AM Neptune Technologies & Bioresources (NEPT +4.4%) rises after saying a class action lawsuit against the firm and some of its officers has been voluntarily dismissed without prejudice. (PR) 1 Comment [On the Move]
- Friday, February 15, 11:08 AM Shares of Neptune Technologies & Bioressources (NEPT +0.8%) return to earth after being up over 8.7% in pre-market trade, after JMP Securities initiated the stock earlier at Outperform with a lofty $6 price target. Comment! [Healthcare, On the Move]
- Tuesday, January 15, 8:11 AM Neptune Technologies & Bioressources (NEPT): Revenue of $7.03M (+37% Y/Y) misses by $1.1M. (PR) Comment! [Earnings, Breaking News, Healthcare]
- Wednesday, December 19, 2012, 2:18 PM Neptune Technologies & Bioressources (NEPT +18%) bounces back after two days of heavy losses, on the back of comments from its CFO that the company expects to resume production of its nutritional supplements next year, with another factory coming on line in about six months. The company's plant in Sherbrooke was destroyed in November by an explosion and fire, killing three workers. 1 Comment [Healthcare, On the Move]
- Tuesday, November 27, 2012, 9:22 AM Neptune Technologies & Bioresources (NEPT) -32% premarket as shares resume trading after being halted since Nov. 8 when an explosion and fire destroyed its production plant in Quebec. As part of an action plan to resume operations and supply customers, the nutritional supplement maker will temporarily lay off ~70 workers while management and employees take salary cuts. Comment! [Healthcare, On the Move]
- Monday, September 24, 2012, 4:35 PM Shares of Neptune Technologies (NEPT) dip in the post-trading session after the company files a secondary offering to sell an undisclosed number of shares. RBC Capital Markets and JMP Securities will act as joint book-runners. Shares -5% AH. 1 Comment [On the Move]
- Friday, September 7, 2012, 2:45 PM Neptune Technologies & Bioressources (NEPT +4.6%) moves up after its board approves dividend-in-kind distribution and a record date for a partial spin-off of its NeuroBioPharm business. 2M shares will be allotted to shareholders of record as of October 15. Each unit will consist of one class A subordinate voting share of NeuroBio and two warrants. Comment! [Healthcare, On the Move]
- Thursday, October 6, 2011, 12:19 PM Neptune Technologies (NEPT +9.5%) trades higher after filing a patent infringement suit against Aker Biomarine ASA, Schiff Nutritional International (WNI +0.4%) and a number of other firms. The suit alleges that the companies are violating it's recently issued omega-3 composition patent. 1 Comment [Healthcare, On the Move]
Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.